Merck | MRK - Gross Profit On Sales



Merck reported EUR3.03B in Gross Profit on Sales for its fiscal quarter ending in June of 2025.


Gross Profit On Sales Change Date
Adidas EUR 3.08B 128M Jun/2025
Adyen EUR 1.08B 788.66M Dec/2024
Akzo Nobel EUR 1.04B 10M Jun/2025
Alcon AG USD 1.39B 5M Jun/2025
Amadeus IT EUR 1.22B 80.9M Mar/2025
Amarin USD 25.13M 1.78M Mar/2025
AstraZeneca USD 11.98B 637M Jun/2025
BASF EUR 4.18B 675M Jun/2025
Bayer EUR 6.38B 1.74B Jun/2025
Beiersdorf EUR 1.54B 1.16B Jun/2025
Covestro EUR 552M 87M Jun/2025
Danone EUR 6.82B 23M Dec/2024
Fresenius EUR 1.46B 47M Jun/2025
Fresenius Medical Care EUR 1.22B 31M Jun/2025
Galapagos EUR 61.25M 98.68M Mar/2025
Genmab DKK 868M 195M Jun/2025
Givaudan CHF 823M 575M Jun/2024
GlaxoSmithKline GBP 5.82B 229M Jun/2025
GRIFOLS EUR 743.8M 49.13M Jun/2025
Henkel EUR 2.65B 2.8B Jun/2025
Hikma Pharmaceutical USD 692M 64M Dec/2024
Infineon EUR 1.52B 124M Jun/2025
Linde USD 4.19B 227M Jun/2025
Lonza CHF 1.04B 72M Dec/2024
Merck EUR 3.03B 118M Jun/2025
Novartis USD 11.51B 1.12B Jun/2025
Philips EUR 2.01B 162M Jun/2025
Roche Holding CHF 11.69B 48M Dec/2024
Sanofi EUR 7.74B 26M Jun/2025
UCB EUR 2.46B 520M Dec/2024